Meitheal Pharmaceuticals Inc
Chicago, IL, United States
3
Total Recalls
1
Class I Recalls
1
Ongoing Recalls
Recalls by Meitheal Pharmaceuticals Inc
FDA Drug
Class II
Ongoing
Cetrorelix Acetate for Injection, 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. Vial: Cetrorelix Acetate for Injection, 0.25 mg per vi
February 9, 2026
Meitheal Pharmaceuticals Inc
16,477 kits units
FDA Drug
Class III
Terminated
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
September 3, 2021
Meitheal Pharmaceuticals Inc
1,160 ten-pack cartons units
FDA Drug
Class I
Terminated
Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meithe
January 27, 2021
Meitheal Pharmaceuticals Inc
34,860 vials units